<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ymj-1850</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Распространенность маркеров НВV- и НСV-инфекций среди больных СД 2 типа</article-title><trans-title-group xml:lang="en"><trans-title>Prevalence of HBV and HCV infections markers among patients with type 2 diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саввин</surname><given-names>Р. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Savvin</surname><given-names>R. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Саввин Реворий Григорьевич – к.м.н., с.н.с., зав. группой</p></bio><bio xml:lang="en"><p>Savvin Revorii Grigorievich, senior scientific worker, Candidate of medical sciences, head of the Group of monitoring and epidemiology of chronic diffuse liver diseases</p><p>Yakutsk, Tel/fax: (411-2) 35-32-75, mob.phone: 8- 9247676441</p></bio><email xlink:type="simple">revoriisavvin@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимова</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Maximova</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимова Светлана Семеновна – с.н.с.</p></bio><bio xml:lang="en"><p>Maximova Svetlana Semenovna, senior scientific worker at the Group of monitoring and epidemiology of chronic diffuse liver diseases</p><p>Yakutsk, Tel/fax (411-2) 35-32-75, mob.phone 8-9841069568</p></bio><email xlink:type="simple">svetlana.maksimo@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ здоровья СВФУ им. М.К. Аммосова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Health Institute, North-Eastern Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>05</day><month>10</month><year>2025</year></pub-date><volume>0</volume><issue>4</issue><fpage>12</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саввин Р.Г., Максимова С.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Саввин Р.Г., Максимова С.С.</copyright-holder><copyright-holder xml:lang="en">Savvin R.G., Maximova S.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/1850">https://ymj.elpub.ru/jour/article/view/1850</self-uri><abstract><p>Изучены частота встречаемости маркеров HBV- и HCV-инфекций и биохимический профиль у больных сахарным диабетом 2 типа (СД 2 типа). Всего обследовано 207 пациентов из разных районов Якутии, обратившихся за период январь–май 2013 г. в Якутский республиканский эндокринологический диспансер. У обследованных больных отмечается высокая инфицированность вирусами гепатита В (71,5%), С (10,8%) и обоими вирусами (7,5%). Частота обнаружения серологических маркеров вируса гепатитов В и С у больных СД 2 типа в 4 раза выше, чем в общей популяции жителей республики. Сочетанная патология (сахарный диабет+вирусный гепатит) ухудшает функции печени и почек. Таким образом, можно считать, что вирусные гепатиты являются факторами риска возникновения и прогрессирования сахарного диабета.</p></abstract><trans-abstract xml:lang="en"><p>Frequency of HBV and HCV markers and biochemical profile of patients with type II diabetes (T2DM) were studied. There were examined 207 patients from different regions of Yakutia who were being consulted at Republican Endocrinology Hospital since January to May 2013 in Yakutsk. Among examined patients there is high contamination with hepatitis B (71,5 %), С (10,8%) or mixed viruses (7,5 %). The frequency of serological markers of viral hepatitis В and С among patients with T2DM is four times higher than among general population in the Republic. Combination of pathology (diabetes + Viral hepatitis) worsens liver and kidneys functions. Thus there can be considered that viral hepatitis is risk factor for diagnosing and progressing of diabetes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>маркеры вируса гепатита В и С</kwd><kwd>сахарный диабет</kwd><kwd>фактор риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>markers of viral hepatitis B and C</kwd><kwd>diabetes</kwd><kwd>risk factor</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Андреева Л.С. Клинико-эпидемиологическое значение HBV и HCV инфекции в развитии и течении сахарного диабета 2-го типа: дис. … канд. мед. наук / Л.С. Андреева. – Иркутск, 2004. – 127 с.</mixed-citation><mixed-citation xml:lang="en">Andreeva L.S. Clinical and epidemiological importance of HBV and HCV infection in development and progression of type 2 diabetes mellitus: diss. … cand. med. sciences/ L.S. Andreeva. – Irkutsk, 2004. – 127 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ахметова М.Т. Клиника вирусного гепатита у больных сахарным диабетом / М.Т. Ахметова // Казан. мед. журн. – 1976. – Т. 57, № 4. – С. 345-346.</mixed-citation><mixed-citation xml:lang="en">Akhmetova М.Т. Clinic of viral hepatitis in patients with diabetes / М.Т. Akhmetova // Kazan. med. journal. – 1976. – V. 57, № 4. – P. 345-346.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Комар В.И. К клинике вирусного гепатита у больных сахарным диабетом / В.И. Комар, С.Б. Юшкевич // Здравоохранение Белоруссии. – 1973. – №5. – С. 25-26.</mixed-citation><mixed-citation xml:lang="en">Komar V.I. To viral hepatitis clinic in patients with diabetes. / V.I.Komar, S.B.Yushkevich // Zdravookhranenie Belorussii. – 1973. – №5. – P. 25-26.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Космачевский В.В. Клиническая характеристика эпидемического гепатита у больных сахарным диабетом / В.В. Космачевский, О. М. Крылова // Терапевт. архив. – 1967. – № 3. – С. 40-44.</mixed-citation><mixed-citation xml:lang="en">Kosmachevskyi V.V. Clinic characteristics of epidemic hepatitis among diabetes patients / V. V. Kosmachevskyi, О. М. Krylova // Terapevt.archiv. – 1967. – № 3. – P. 40-44.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко Г.Г. Ситуация и меры борьбы с вирусными гепатитами в Российской Федерации / Г.Г. Онищенко // Медиц. кафедра. – 2002. – № 2. – С. 18-22.</mixed-citation><mixed-citation xml:lang="en">Onishenko G.G. Situation and control measures with viral hepatitis in the Russian Federation / G.G. Onishenko // Medic.kafedra. – 2002. – № 2. – P. 18-22.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">IDF Diabetes Atlas, 5th ed., 2011.</mixed-citation><mixed-citation xml:lang="en">IDF Diabetes Atlas, 5th ed., 2011.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization, Fortysecond world health assembly, Geneva 8- 19 May Resolutions and decisions, Annexes (WHA42/1989/REC/1). 1989.</mixed-citation><mixed-citation xml:lang="en">World Health Organization, Fortysecond world health assembly, Geneva 8- 19 May Resolutions and decisions, Annexes (WHA42/1989/REC/1). 1989.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
